BioScrip completes buyout of Critical Homecare
Pharmacy benefits manager BioScrip Inc. said Thursday it completed its buyout of Critical Homecare Solutions for $237.9 million in cash and $109.8 million in stock.
A NEW specialist dementia care home in Malvern is nearing completion ahead of its projected opening early next year.